Abstract In a prospective, double-blind controlled study we have compared the prophylactic efficacy against deep vein thrombosis of low-dose heparin + dihydroergotamine (A), low molecular weight heparin + dihydro-ergotamine (B) and placebo (C). A total of three hundred and fifty-six patients undergo
✦ LIBER ✦
Low molecular weight heparin plus dihydroergotamine for prophylaxis of postoperative deep vein thrombosis
✍ Scribed by Professor A. A. Sasahara; K. Koppenhagen; R. Häring; D. Welzel; H. Wolf
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 497 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0007-1323
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Heparin/dihydroergotamine for venous thr
✍
Dr. M. R. Lassen; L. C. Borris; H. M. Christiansen; F. Møller-Larsen; V. E. Knud
📂
Article
📅
1988
🏛
John Wiley and Sons
🌐
English
⚖ 495 KB
👁 1 views
Low molecular weight heparins and preven
✍
H. Bounameaux; D. Bergqvist; T. Mätzsch; U. S. Burmark; J. Frisell; O. Guilbaud;
📂
Article
📅
1989
🏛
John Wiley and Sons
🌐
English
⚖ 155 KB
👁 1 views
Low molecular weight heparin started bef
✍
J. Daniš; D. Bergqvist
📂
Article
📅
1995
🏛
John Wiley and Sons
🌐
English
⚖ 276 KB
👁 2 views
Randomized study of adjusted versus fixe
✍
D. A. Taberner; Dr L. Poller; J. M. Thomson; G. Lemon; F. J. Weighill
📂
Article
📅
1989
🏛
John Wiley and Sons
🌐
English
⚖ 328 KB
👁 2 views
Low-molecular-weight Heparin for the tre
✍
Eikelboom, John W.; Baker, Ross I.
📂
Article
📅
1998
🏛
John Wiley and Sons
🌐
English
⚖ 36 KB
👁 2 views
This case further supports
Home treatment of deep venous thrombosis
✍
Enric Grau; Jose M. Tenias; Esperanza Real; Jose Medrano; Rosario Ferrer; Emilio
📂
Article
📅
2001
🏛
John Wiley and Sons
🌐
English
⚖ 37 KB
👁 2 views
## Abstract Outpatient treatment of deep venous thrombosis (DVT) with low molecular weight heparin (LMWH) seems as safe and effective as inpatient treatment with unfractionated heparin (UFH). However, most of the randomized trials comparing a LMWH with UFH described clinical outcomes within 3–6 mon